Bragar Eagel &amp; Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In GE HealthCare (GEHC) To Contact Him Directly To Discuss Their Options  If you purchased or acquired stock

GEHC

Bragar Eagel & Squire, P.C. Continues Investigating GE HealthCare Technologies Inc. on Behalf of GE HealthCare Stockholders and Encourages Investors to Contact the Firm

GE HealthCare under investigation for potential securities law violations


The law firm of Kirby McInerney LLP continues its investigation on behalf of GE HealthCare Technologies Inc. (&#34;GE HealthCare&#34; or the &#34;Company&#34;) (NASDAQ:GEHC) investors concerning the Company&#39;s and/or members of its

GEHC INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving GE HealthCare Technologies Inc.

<section class="insight" data-version="1">
  <section data-block="information">
    <h3>Information</h3>
    <p>Bragar Eagel &amp;amp; Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In GE HealthCare (GEHC) To Contact Him Directly To Discuss Their Options  If you purchased or acquired stock</p>
  </section>

  <section data-block="ai-summary-paragraph">
    <h3>AI Summary</h3>
    <p>GE HealthCare is currently under investigation for possible federal securities law violations following a disappointing earnings announcement. The company missed EPS estimates and reduced full-year guidance, which caused a significant drop in its share price, suggesting heightened legal and financial risks ahead.</p>
  </section>

  <section data-block="ai-summary-bullets">
    <h3>Key Points</h3>
    <ul><li>GE HealthCare faces investigation over potential violations of federal securities laws.</li><li>Recent earnings report showed EPS of $0.99, below $1.05 consensus estimate.</li><li>Full-year EPS guidance reduced from $4.95-$5.15 to $4.80-$5.00.</li><li>Shares dropped 13% following the disappointing earnings results and guidance cut.</li><li>Investors with losses encouraged to contact Bragar Eagel &amp; Squire for legal rights.</li></ul>
  </section>

  <section data-block="companies-mentioned">
    <h3>Companies Mentioned</h3>
    <ul><li><strong>Bragar Eagel &amp; Squire, P.C. (N/A)</strong>: A law firm investigating potential claims may highlight legal risks.</li></ul>
  </section>

  <section data-block="category">
    <h3>Corporate Developments</h3>
    <p>This news falls under &#039;Corporate Developments&#039; due to the legal investigation implications, presenting potential risks and volatility for GE HealthCare shares.</p>
  </section>

  <section data-block="market-moving">
    <h3>Market-Moving</h3>
    <ul><li>Missed EPS estimates and reduced guidance heightens investor concerns.</li><li>Legal investigation could lead to further stock volatility.</li><li>Executive comments regarding profitability issues may deter future investments.</li><li>Continued pressure from investor sentiment could further depress share price.</li></ul>
  </section>

  <section data-block="key-facts">
    <h3>Key Facts</h3>
    <ul><li>Q1 2026 EPS of $0.99 missed consensus by $0.06.</li><li>Full-year EPS guidance lowered to $4.80-$5.00 from $4.95-$5.15.</li><li>Share price fell from $68.50 to $59.49, a 13% decrease.</li><li>Investigation initiated by Bragar Eagel &amp; Squire, P.C.</li><li>CEO cited a resolution to supply issues impacting profitability.</li></ul>
  </section>

  <section data-block="trading-thesis">
    <h3>Trading Thesis</h3>
    <p>Short-term bearish sentiment on GEHC due to earnings miss and legal concerns.</p>
  </section>
</section>


<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css"></link><p align="justify"><strong>Bragar Eagel &amp; Squire, P.C. </strong><strong>Litigation Partner </strong><a href="https://www.globenewswire.com/Tracker?data=AfkiDMULlltWZwfbQ9pd4OG5INBsoFjiyK4kmmQi0aIcxg6oSxZ6x3aRxXrOLmEVY7-fX12lJt9DYtliSTN5JXwSyetfuQB9Fo9pCM5_95fWpnvPSTj1meMEp8tHwqrt" rel="nofollow" target="_blank"><strong>Brandon Walker</strong></a><strong> Encourages Investors Who Suffered Losses In GE HealthCare (GEHC) To Contact Him Directly To Discuss Their Options</strong></p>  <p align="justify"><strong>If you purchased or acquired stock in </strong><strong>GE HealthCare</strong><strong> and would like to discuss your legal rights, call Bragar Eagel &amp; Squire partner Brandon Walker or Melissa Fortunato directly at (212) 355-4648.</strong></p>  <p align="justify">Click <a href="https://www.globenewswire.com/Tracker?data=PLfFf-I081sCOMZy5hmRaxZbB0d-zgYh7AxKsBNfl0yvNh12jnG1gjdWER11q-DwiYOJOPbBx8s2u61VVicYbw==" rel="nofollow" target="_blank">here</a> to participate in the action.</p>  <p align="justify">NEW YORK, May  19, 2026  (GLOBE NEWSWIRE) -- </p>  <p align="justify"><strong>What's Happening:</strong></p>  <ul type="circle"><li style="margin-bottom:12pt; text-align:justify;"><a href="https://www.bespc.com" rel="nofollow" target="_blank">Bragar Eagel &amp; Squire, P.C</a>., a nationally recognized stockholder rights law firm, is investigating potential claims against GE HealthCare Technologies Inc. ("GE HealthCare" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/GEHC">GEHC</a>) on behalf of GE HealthCare stockholders. Our investigation concerns whether GE HealthCare has violated the federal securities laws and/or engaged in other unlawful business practices.<br></br><br></br></li></ul>  <p align="justify"><strong>Investigation Details:</strong></p>  <ul type="circle"><li style="margin-bottom:12pt; text-align:justify;">On April 29, 2026, GE HealthCare announced its financial results for the first quarter of 2026. Among other disclosures, the Company reported adjusted earnings per share of $0.99, missing the consensus estimate of $1.05, and reduced its full-year 2026 adjusted EPS guidance to a range of $4.80 to $5.00 from its prior guidance of $4.95 to $5.15. During the related earnings call, CEO Peter Arduini stated that "profitability in the first quarter was impacted by a PDx supplier issue that has since been resolved." Following this news, the price of GE HealthCare shares fell by $9.01 per share, or approximately 13%, declining from $68.50 per share on April 28, 2026 to close at $59.49 per share on April 29, 2026.<br></br><br></br></li></ul>  <p align="justify"><strong>Next Steps:</strong></p>  <ul type="circle"><li style="text-align:justify;">If you purchased or otherwise acquired GE HealthCare shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact <a href="https://www.bespc.com/professionals/brandon-walker" rel="nofollow" target="_blank">Brandon Walker</a> or <a href="https://www.bespc.com/professionals/melissa-fortunato" rel="nofollow" target="_blank">Melissa Fortunato</a> by email at <a href="mailto:investigations@bespc.com" rel="nofollow" target="_blank">investigations@bespc.com</a>, by telephone at (212) 355-4648, or by <a href="https://bespc.com/cases/GEHC" rel="nofollow" target="_blank">filling out this contact form</a>.  There is no cost or obligation to you.<br></br><br></br></li></ul>  <p align="justify"><strong>About Bragar Eagel &amp; Squire, P.C.:</strong></p>  <p align="justify">Bragar Eagel &amp; Squire, P.C. is a nationally recognized law firm with offices in New York, South Carolina, and California. The firm represents individual and institutional investors in securities, derivative, and commercial litigation as well as individuals in consumer protection and data privacy litigation. The firm has a nationwide practice and routinely handles cases in both federal and state courts. For more information about the firm, please visit <a href="https://www.globenewswire.com/Tracker?data=zvvHtTxondo0F0yWfa2SF4FphjEqzglV7bfam-QkRfZMWejNRa0w67yg8r1i6X9ugYTpKBoDS78UMaOCt9GNlA==" rel="nofollow" target="_blank">www.bespc.com</a>.  Attorney advertising.  Prior results do not guarantee similar outcomes.</p>  <p align="justify">Follow us for updates on <a href="https://www.globenewswire.com/Tracker?data=InUNCWS3_peDanObOQw7R8NUHeI2mZeTT8pqDzMdWXguCi3DID8TkBMuRT18hV4liHMy_uWW5O332Gqelk-eU581881QK-s5Wrmm9qwyVp7NlmtEYn1k_bu0UYDxsrqR" rel="nofollow" target="_blank">LinkedIn</a> and <a href="https://www.globenewswire.com/Tracker?data=UvvYBbZiV4OkJhL9KcJlNATQ2dYvfs9MJChqgIZih5U6ahyGT1I0XY-ERLtZmNcnzp0yOCnPfP2GD4AAA9_wW-66iVD-fHyIAF-sScjEHHq7gVr9qcW3_Ycn3oh8QJaI" rel="nofollow" target="_blank">Facebook</a>, and keep up with other news by following Brandon Walker, Esq. on <a href="https://www.globenewswire.com/Tracker?data=InUNCWS3_peDanObOQw7Rwz0qz5GYIbPe0aGJ951nQj3oHWzAiSNy0gl3v2vOcNHgrofRhKT-LR9N2hED0jfEoqJNiHHdD_r6uRHIR-lmvmfD4jfQ9y8zf4vRjJxGPcl" rel="nofollow" target="_blank">LinkedIn</a>.</p>  <p align="justify"><strong>Contact Information:</strong></p>  <p align="justify">Bragar Eagel &amp; Squire, P.C.<br></br>Brandon Walker, Esq.<br></br>Melissa Fortunato, Esq.<br></br>(212) 355-4648<br></br><a href="https://www.globenewswire.com/Tracker?data=MVUSWjdlLtnNuC0iPIAQYi0LY10HoTV7uVZdvLeGT2ZH399NcIFACMLZrEVUIr4rdOGjyHbOrQjYmdpp9wbtCI651xt-DyzF70iGhcIIci9ZPWVjiOfQX8VC-qycp31Y" rel="nofollow" target="_blank"><u>investigations@bespc.com</u></a><br></br><a href="https://www.globenewswire.com/Tracker?data=zvvHtTxondo0F0yWfa2SF92kvgu2-pAl6_hj_Zz7XDm1cSLNQHjOcpMv2qM7vOn79xPCK-EAWIT0jysU4pjufQ==" rel="nofollow" target="_blank"><u>www.bespc.com</u></a></p> <img alt="" class="__GNW8366DE3E__IMG" src="https://www.globenewswire.com/newsroom/ti?nf=OTcyMzUzMiM3NjEyMzY0IzIxMDAzOTg="></img> <br></br><img alt="" src="https://ml.globenewswire.com/media/YzQ3NjM2NDItYjRjMS00NmMxLWJiNTQtNzk0NWZkNTE4ZWViLTExMTE5NjktMjAyNi0wNS0xOS1lbg==/tiny/Bragar-Eagel-Squire.png" referrerpolicy="no-referrer-when-downgrade"></img><p><a href="https://www.globenewswire.com/NewsRoom/AttachmentNg/29481954-f2ff-4756-b5a9-d982a6497bd0"><img src="https://ml.globenewswire.com/media/29481954-f2ff-4756-b5a9-d982a6497bd0/small/bes-mark-jpg.jpg" border="0" width="150" height="75" alt="Primary Logo"></img></a></p>

GE HealthCare is currently under investigation for possible federal securities law violations following a disappointing earnings announcement. The company missed EPS estimates and reduced full-year guidance, which caused a significant drop in its share price, suggesting heightened legal and financial risks ahead.

bragar-eagel-squire-p-c-continues-investigating-ge-healthcare-technologies-inc-on-behalf-of-ge-healthcare-stockholders-and-encourages-investors-to-contact-the-firm

Bragar Eagel & Squire, P.C. Continues Investigating GE HealthCare Technologies Inc. on Behalf of GE HealthCare Stockholders and Encourages Investors to Contact the Firm

AI Summary

Sentiment Rationale

Trading Thesis

Market-Moving

Key Facts

Companies Mentioned

Corporate Developments

Related News